Scientific Literature Search

Open access

Atorvastatin Shows Limited Disease-Modifying Effects in an A53T α-Synuclein Mouse Model of Parkinson's Disease.

Wei L, Hua J, Tang S, Lei J, Li G, Wei L, Mo M.

Neurotox Res · 2026-09-09

DOI: 10.1007/s12640-026-00825-yPMID: 42714756

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Eating Disorders and Parkinson's Disease-2: Genetic Epidemiology and Shared Genomics.

Bergen AW, Makowski C, Garvin M, Cil G, Krueger A, McGlone K, Litvan I, Hower H, Kaye WH.

Eur Eat Disord Rev · 2026-09-09

DOI: 10.1002/erv.70158PMID: 42717474

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Seed amplification of released alpha-synuclein strains reveals genotype-specific differences in Parkinson's disease neurons.

Chedid J, Tang Y, Law K, Thompson L, Gambin Y, Sierecki E, Dzamko N.

Front Aging Neurosci · 2026-09-08

DOI: 10.3389/fnagi.2026.1917981PMID: 42774389

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

When Pathologies Collide: The Intersection of Tau and Alpha-Synuclein in Neurodegenerative Diseases.

Hunt JN, Kortagere S.

Mol Neurobiol · 2026-09-08

DOI: 10.1007/s12035-026-06163-6PMID: 42706463

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

From Glycation to Toxicity: α-Synuclein Oligomers, Oxidative Stress, and Multi-Targeted Protection by Trans-Ferulic Acid.

Hussain M, Hassan MN, Ahmad R, Zehra GE, Kaur A, Baliyavi UK, Aziz T, Khan RH, Siddiqui WA.

Cell Biochem Biophys · 2026-09-08

DOI: 10.1007/s12013-026-02150-9PMID: 42709392

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Chemical Genetic Targeting of the LRRK2 GTPase Domain

Prorok RE, Zhu LY, Bowcut V, Wu H, Guiley KZ, Morstein J, Shokat KM.

· 2026-09-07

DOI: 10.64898/2026.09.03.749217

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Synaptic vesicle glycoprotein 2A PET imaging in parkinsonian α-synucleinopathies: a systematic review.

Garrou F, Leva L, Sacchetti GM, De Natale ER, Tondo G, Comi C.

J Neurol · 2026-09-07

DOI: 10.1007/s00415-026-14123-2PMID: 42704496

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Biologically-synthesized zinc oxide nanoparticle-based α-synuclein nanoformulation mitigates Parkinson's disease progression in Drosophila melanogaster.

Jena S, Subham K, Kalra H, Naik S, Sahu DD, Mishra M, Jha S.

Int J Biol Macromol · 2026-09-07

DOI: 10.1016/j.ijbiomac.2026.154365PMID: 42705562

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

Detection of α-synuclein seeding activity in tear fluid as a candidate biomarker for Parkinson's disease.

Kakimoto A, Satoh K, Tsukahara-Kawamura T, Tsuboi Y.

J Parkinsons Dis · 2026-09-07

DOI: 10.1177/1877718x261486736PMID: 42706613

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

LRRK2 variant spectrum and association study in a multi-ethnic cohort of Malaysian Parkinson’s disease patients

Lim KS, Lim JL, Periñan MT, Tay YW, Toh TS, Lit L, Anuar ANK, Ding HX, Ibrahim KA, Mawardi AS, Chia YK, Ooi JCE, Lim TT, Looi I, Schee JP, Beh YY, Cheah WK, Law WC, Wong SC, Ong TL, Chin ML, Teh PC, Lau YH, Lee CLL, Screven L, Bandres-Ciga S, Lim S, Tan AH, Ahmad-Annuar A.

· 2026-09-04

DOI: 10.21203/rs.3.rs-9924440/v1

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

Protocol to quantify LRRK2-mediated Rab10 phosphorylation using high-content imaging.

Masotti B, Lorenzon P, Covello G, Greggio E.

STAR Protoc · 2026-09-04

DOI: 10.1016/j.xpro.2026.104819PMID: 42696457

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Parkinson's disease-associated LRRK2 G2019S enhances intestinal neutrophil extracellular trap formation through RAB10–myeloperoxidase signaling and promotes enteric α-synuclein accumulation

Cheng Y, Leong K, Lin P, Chen M, Lin C, Hsiao Y, Wang J, Ma S, Lin Y, Su J, Shih H, Cheng C, Chen H, Lin S, Lin C, Chiang H.

· 2026-09-03

DOI: 10.21203/rs.3.rs-10900990/v1

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

14.182 articles found

Atorvastatin Shows Limited Disease-Modifying Effects in an A53T α-Synuclein Mouse Model of Parkinson's Disease.

Eating Disorders and Parkinson's Disease-2: Genetic Epidemiology and Shared Genomics.

Seed amplification of released alpha-synuclein strains reveals genotype-specific differences in Parkinson's disease neurons.

When Pathologies Collide: The Intersection of Tau and Alpha-Synuclein in Neurodegenerative Diseases.

From Glycation to Toxicity: α-Synuclein Oligomers, Oxidative Stress, and Multi-Targeted Protection by Trans-Ferulic Acid.

Chemical Genetic Targeting of the LRRK2 GTPase Domain

Synaptic vesicle glycoprotein 2A PET imaging in parkinsonian α-synucleinopathies: a systematic review.

Biologically-synthesized zinc oxide nanoparticle-based α-synuclein nanoformulation mitigates Parkinson's disease progression in Drosophila melanogaster.

Detection of α-synuclein seeding activity in tear fluid as a candidate biomarker for Parkinson's disease.

LRRK2 variant spectrum and association study in a multi-ethnic cohort of Malaysian Parkinson’s disease patients

Protocol to quantify LRRK2-mediated Rab10 phosphorylation using high-content imaging.

Parkinson's disease-associated LRRK2 G2019S enhances intestinal neutrophil extracellular trap formation through RAB10–myeloperoxidase signaling and promotes enteric α-synuclein accumulation

Filters